Loading…

Reactivation of latent HIV-1 in vitro using an ethanolic extract from Euphorbia umbellata (Euphorbiaceae) latex

Euphorbia umbellata (E. umbellata) belongs to Euphorbiaceae family, popularly known as Janauba, and its latex contains a combination of phorbol esters with biological activities described to different cellular protein kinase C (PKC) isoforms. Here, we identified deoxi-phorbol esters present in E. um...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2018-11, Vol.13 (11), p.e0207664
Main Authors: Valadão, Ana Luiza Chaves, Pezzuto, Paula, Silva, Viviane A Oliveira, Gonçalves, Barbara Simonson, Rossi, Átila Duque, da Cunha, Rodrigo Delvecchio, Siani, Antonio Carlos, Tostes, João Batista de Freitas, Trovó, Marcelo, Damasco, Paulo, Gonçalves, Gabriel, Reis, Rui Manuel, Aguiar, Renato Santana, Bento, Cleonice Alves de Melo, Tanuri, Amilcar
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Euphorbia umbellata (E. umbellata) belongs to Euphorbiaceae family, popularly known as Janauba, and its latex contains a combination of phorbol esters with biological activities described to different cellular protein kinase C (PKC) isoforms. Here, we identified deoxi-phorbol esters present in E. umbellata latex alcoholic extract that are able to increase HIV transcription and reactivate virus from latency models. This activity is probably mediated by NF-kB activation followed by nuclear translocation and binding to the HIV LTR promoter. In addition, E. umbellata latex extract induced the production of pro inflammatory cytokines in vitro in human PBMC cultures. This latex extract also activates latent virus in human PBMCs isolated from HIV positive patients as well as latent SIV in non-human primate primary CD4+ T lymphocytes. Together, these results indicate that the phorbol esters present in E. umbellata latex are promising candidate compounds for future clinical trials for shock and kill therapies to promote HIV cure and eradication.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0207664